Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2023-06-28
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Evaluation and Management in Heart Failure
NCT02998788
Demographic and Clinical Characteristics, Treatment Patterns and Clinical Outcomes of Heart Failure Patients in China
NCT03931200
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985
Study of China Heart Failure Registry to Investigate Characteristics of Patients in China
NCT02664818
China National Heart Failure Registry
NCT02079428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFrEF group
HFrEF was defined as Left ventricular ejection fraction ≤40%
No interventions assigned to this group
HFmrEF group
HFmrEF was defined as Left ventricular ejection fraction 41%\~49%
No interventions assigned to this group
HFpEF group
HFpEF was defined as Left ventricular ejection fraction ≥50%
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The diagnosis of heart failure conforms to the criteria of the Chinese Guidelines for the Diagnosis and Treatment of Heart Failure .
3. Echocardiography, dynamic electrocardiogram and polysomnography monitoring should be improved during the period of hospitalization.
4. Patients with sleep apnea have not received standard treatment.
Exclusion Criteria
2. Patients with acute decompensated heart failure or heart failure requiring oxygen therapy.
3. All patients with sleep apnea who receive standard treatment.
4. Patients who use pacemakers or implantable cardioverter defibrillators.
5. The patient did not complete the echocardiography, dynamic electrocardiogram, and polysomnography monitoring during hospitalization.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yihui Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yihui Kong
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yihui Kong
Harbin, Heilongjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021020707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.